The table below shows GoodRx Holdings, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$796.85M
$792.32M
$750.26M
$766.55M
$745.42M
$550.70M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$121.03M
$123.75M
$135.84M
$143.14M
$125.86M
$61.82M
SG&A
GDRX annual revenue (10-K history)
GoodRx Holdings, Inc. reported annual revenue of $796.85M for fiscal year 2025. That is up 0.6% from $792.32M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $249.52M (FY 2018) to $796.85M. Figures come from the company's audited annual reports as filed with the SEC.
